Tapan Chowdhury plans Tk40cr share purchase in Square Pharma
Since 2020, four directors of Square Pharmaceuticals have collectively bought about 1.51 crore shares of
‘R-category’ board proposed for long-term non-performing stocks
Settlement for R-category stocks will be seven days, and selling will be restricted for one